Warris A, Lehrnbecher T, Roilides E, Castagnola E, Brüggemann RJM, Groll AH (2019) ESCMID-ECMM Guideline: Diagnosis and Management of Invasive Aspergillosis in Neonates and Children. Clin Microbiol Infect 25:1096–1113. https://doi.org/10.1016/j.cmi.2019.05.019
Article CAS PubMed Google Scholar
Papachristou S, Iosifidis E, Roilides E (2019) Invasive Aspergillosis in Pediatric Leukemia Patients: Prevention and Treatment. J Fungi Basel Switz 5:E14. https://doi.org/10.3390/jof5010014
Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T (2017) Epidemiology of Invasive Fungal Disease in Children. J Pediatr Infect Dis Soc 6:S3–S11. https://doi.org/10.1093/jpids/pix046
Karlsson MO, Lutsar I, Milligan PA (2009) Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies. Antimicrob Agents Chemother 53:935–944. https://doi.org/10.1128/AAC.00751-08
Article CAS PubMed Google Scholar
Lestrade PP, Bentvelsen RG, Schauwvlieghe AFAD, Schalekamp S, van der Velden WJFM, Kuiper EJ, van Paassen J, van der Hoven B, van der Lee HA, Melchers WJG et al (2019) Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study. Clin Infect Dis Off Publ Infect Dis Soc Am 68:1463–1471. https://doi.org/10.1093/cid/ciy859
Jin H, Wang T, Falcione BA, Olsen KM, Chen K, Tang H, Hui J, Zhai S (2016) Trough Concentration of Voriconazole and Its Relationship with Efficacy and Safety: A Systematic Review and Meta-Analysis. J Antimicrob Chemother 71:1772–1785. https://doi.org/10.1093/jac/dkw045
Article CAS PubMed PubMed Central Google Scholar
Bartelink IH, Wolfs T, Jonker M, de Waal M, Egberts TCG, Ververs TT, Boelens JJ, Bierings M (2013) Highly Variable Plasma Concentrations of Voriconazole in Pediatric Hematopoietic Stem Cell Transplantation Patients. Antimicrob Agents Chemother 57:235–240. https://doi.org/10.1128/AAC.01540-12
Article CAS PubMed PubMed Central Google Scholar
Andes D, Marchillo K, Stamstad T, Conklin R (2003) In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis Model. Antimicrob Agents Chemother 47:3165–3169. https://doi.org/10.1128/AAC.47.10.3165-3169.2003
Article CAS PubMed PubMed Central Google Scholar
Faghihi T, Tiihonen M (2021) Voriconazole Therapeutic Drug Monitoring: How to Adjust the Dose in Pediatrics? Iran. J Pediatr 31. https://doi.org/10.5812/ijp.111582
Jeans AR, Howard SJ, Al-Nakeeb Z, Goodwin J, Gregson L, Warn PA, Hope WW (2012) Combination of Voriconazole and Anidulafungin for Treatment of Triazole-Resistant Aspergillus Fumigatus in an in Vitro Model of Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother 56:5180–5185. https://doi.org/10.1128/AAC.01111-12
Article CAS PubMed PubMed Central Google Scholar
Wang T, Xie J, Wang Y, Zheng X, Lei J, Wang X, Dong H, Yang Q, Chen L, Xing J et al (2015) Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections. Pharmacotherapy 35:797–804. https://doi.org/10.1002/phar.1631
Article CAS PubMed Google Scholar
Soler-Palacin P, Frick MA, Martin-Nalda A, Lanaspa M, Pou L, Rosello E, Diaz de Heredia C, Figueras C (2012) Voriconazole Drug Monitoring in the Management of Invasive Fungal Infection in Immunocompromised Children: A Prospective Study. J Antimicrob Chemother 67:700–706. https://doi.org/10.1093/jac/dkr517
Article CAS PubMed Google Scholar
Bellmann R, Smuszkiewicz P (2017) Pharmacokinetics of Antifungal Drugs: Practical Implications for Optimized Treatment of Patients. Infection 45:737–779. https://doi.org/10.1007/s15010-017-1042-z
Article CAS PubMed PubMed Central Google Scholar
Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O (2008) Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes. Clin Infect Dis 46:201–211. https://doi.org/10.1086/524669
Article CAS PubMed Google Scholar
Park WB, Kim N-H, Kim K-H, Lee SH, Nam W-S, Yoon SH, Song K-H, Choe PG, Kim NJ, Jang I-J et al (2012) The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial. Clin Infect Dis Off Publ Infect Dis Soc Am 55:1080–1087. https://doi.org/10.1093/cid/cis599
Ashbee HR, Barnes RA, Johnson EM, Richardson MD, Gorton R, Hope WW (2014) Therapeutic Drug Monitoring (TDM) of Antifungal Agents: Guidelines from the British Society for Medical Mycology. J Antimicrob Chemother 69:1162–1176. https://doi.org/10.1093/jac/dkt508
Article CAS PubMed Google Scholar
Neely M, Margol A, Fu X, van Guilder M, Bayard D, Schumitzky A, Orbach R, Liu S, Louie S, Hope W (2015) Achieving Target Voriconazole Concentrations More Accurately in Children and Adolescents. Antimicrob Agents Chemother 59:3090–3097. https://doi.org/10.1128/AAC.00032-15
Article CAS PubMed PubMed Central Google Scholar
Dolton MJ, Ray JE, Chen SC-A, Ng K, Pont LG, McLachlan AJ (2012) Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring. Antimicrob Agents Chemother 56:4793–4799. https://doi.org/10.1128/AAC.00626-12
Article CAS PubMed PubMed Central Google Scholar
Choi S-H, Lee S-Y, Hwang J-Y, Lee SH, Yoo KH, Sung KW, Koo HH, Kim Y-J (2013) Importance of Voriconazole Therapeutic Drug Monitoring in Pediatric Cancer Patients with Invasive Aspergillosis. Pediatr Blood Cancer 60:82–87. https://doi.org/10.1002/pbc.24262
Article CAS PubMed Google Scholar
Kang HM, Lee HJ, Cho EY, Yu K-S, Lee H, Lee JW, Kang HJ, Park KD, Shin HY, Choi EH (2015) The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections. Pediatr Hematol Oncol 32:557–567. https://doi.org/10.3109/08880018.2015.1088905
Article CAS PubMed Google Scholar
Ruiz J, Gordon M, Villarreal E, Peruccioni M, Marqués MR, Poveda-Andrés JL, Castellanos-Ortega Á, Ramirez P (2019) Impact of Voriconazole Plasma Concentrations on Treatment Response in Critically Ill Patients. J Clin Pharm Ther 44:572–578. https://doi.org/10.1111/jcpt.12817
Article CAS PubMed Google Scholar
Kadam RS, Van Den Anker JN (2016) Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy. Clin Pharmacokinet 55:1031–1043. https://doi.org/10.1007/s40262-016-0379-2
Article CAS PubMed Google Scholar
Hanai Y, Hamada Y, Kimura T, Matsumoto K, Takahashi Y, Fujii S, Nishizawa K, Takesue Y (2021) Optimal Trough Concentration of Voriconazole with Therapeutic Drug Monitoring in Children: A Systematic Review and Meta-Analysis. J Infect Chemother Off J Jpn Soc Chemother 27:151–160. https://doi.org/10.1016/j.jiac.2020.11.014
Boast A, Curtis N, Cranswick N, Gwee A (2016) Voriconazole Dosing and Therapeutic Drug Monitoring in Children: Experience from a Paediatric Tertiary Care Centre. J Antimicrob Chemother 71:2031–2036. https://doi.org/10.1093/jac/dkw056
Article CAS PubMed Google Scholar
Li H, Li M, Yan J, Gao L, Zhou L, Wang Y, Li Q, Wang J, Chen T, Wang T et al (2020) Voriconazole Therapeutic Drug Monitoring in Critically Ill Patients Improves Efficacy and Safety of Antifungal Therapy. Basic Clin Pharmacol Toxicol bcpt.13465. https://doi.org/10.1111/bcpt.13465
Troke PF, Hockey HP, Hope WW (2011) Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients▿. Antimicrob Agents Chemother 55:4782–4788. https://doi.org/10.1128/AAC.01083-10
Article CAS PubMed PubMed Central Google Scholar
Zane NR, Thakker DR (2014) A Physiologically Based Pharmacokinetic Model for Voriconazole Disposition Predicts Intestinal First-Pass Metabolism in Children. Clin Pharmacokinet 53:1171–1182. https://doi.org/10.1007/s40262-014-0181-y
Article CAS PubMed Google Scholar
Luong M-L, Al-Dabbagh M, Groll AH, Racil Z, Nannya Y, Mitsani D, Husain S (2016) Utility of Voriconazole Therapeutic Drug Monitoring: A Meta-Analysis. J Antimicrob Chemother 71:1786–1799. https://doi.org/10.1093/jac/dkw099
留言 (0)